Table 2 Characteristics of participants categorized by body mass index and blood pressure status
|  | Body mass index < 21.0 kg/m2 N = 216 |  | Body mass index ≥21.0 kg/m2 N = 601 |  | ||||
|---|---|---|---|---|---|---|---|---|
Characteristics | Normotension | Prehypertension | Hypertension | P-value | Normotension | Prehypertension | Hypertension | P-value |
N = 817 | N = 62 | N = 90 | N = 64 | N = 97 | N = 245 | N = 259 | ||
Age (years) | 65 ± 10 | 69 ± 9 | 68 ± 8 | 0.083 | 63 ± 8 | 67 ± 9 | 66 ± 9 | 0.002 |
Body mass index (kg/m2) | 19.4 ± 1.0 | 19.6 ± 1.1 | 19.6 ± 1.1 | 0.341 | 23.6 ± 2.1 | 23.7 ± 2.1 | 24.5 ± 2.4 | < 0.001 |
Alcohol consumption (%) | 40.3/21.0/11.2/27.4 | 34.4/27.8/10.0/27.8 | 37.5/10.9/6.3/45.3 | 0.099 | 43.3/19.6/10.3/26.8 | 37.1/27.3/8.6/26.9 | 42.5/22.8/8.1/26.6 | 0.731 |
Smoking status (%) | 30.6/37.1/21.0/11.3 | 26.7/28.9/32.2/12.2 | 18.8/26.6/21.9/32.8 | 0.011 | 22.7/30.9/25.8/20.6 | 30.6/30.2/22.4/16.7 | 19.7/24.3/29.3/26.6 | 0.012 |
History of CVD, N (%) | 3 (4.8) | 10 (11.1) | 3 (4.7) | 0.214 | 6 (6.2) | 28 (11.4) | 18 (6.9) | 0.130 |
Triglycerides (mg/dL) | 79 (57-97) | 79 (63-100) | 80 (62-108) | 0.266 | 110 (74-151) | 99 (74-144) | 100 (72-146) | 0.997 |
HDL cholesterol (mg/dL) | 68 ± 17 | 64 ± 16 | 70 ± 18 | 0.110 | 55 ± 16 | 57 ± 15 | 58 ± 14 | 0.278 |
LDL cholesterol (mg/dL) | 101 ± 27 | 102 ± 28 | 108 ± 31 | 0.327 | 118 ± 29 | 114 ± 30 | 114 ± 33 | 0.396 |
Antilipidemic medication, N (%) | 0 | 2 (2.2) | 1 (1.6) | 0.511 | 6 (6.2) | 17 (6.9) | 11 (4.2) | 0.413 |
Fasting plasma glucose (mg/dL) | 95 (89-111) | 97 (89-112) | 102 (94-120) | 0.213 | 102 (92-116) | 103 (91-117) | 102 (94-120) | 0.141 |
Antiidiabetic medication, N (%) | 4 (6.5) | 0 | 2 (3.1) | 0.058 | 3 (3.1) | 18 (7.3) | 15 (5.8) | 0.322 |
Serum uric acid (mg/dL) | 5.1 ± 1.1 | 5.4 ± 1.3 | 5.6 ± 1.2 | 0.059 | 6.0 ± 1.1 | 5.8 ± 1.3 | 5.6 ± 1.3 | 0.044 |
eGFR (ml/min./1.73m2) | 81.0 ± 14.8 | 78.3 ± 12.9 | 80.9 ± 14.4 | 0.372 | 76.8 ± 13.4 | 76.4 ± 14.5 | 78.5 ± 15.1 | 0.252 |
Aspartate transaminase (IU/L) | 19 (15-24) | 17 (13-22) | 18 (14-24) | 0.102 | 18 (15-24) | 20 (15-26) | 20 (16-27) | 0.084 |
γ-glutamyl transpeptidase (IU/L) | 27 (20-37) | 27 (19-38) | 35 (21-64) | 0.004 | 29 (21-43) | 34 (22-50) | 36 (25-65) | < 0.001 |